Management of Castration-Resistant Prostate Cancer
The type of prostate cancer known as castration resistant prostate is that which has become resistance to hormonal therapy. It has been discovered that androgen/ testosterone increase the risk of prostate cancer in the body. Application of hormonal therapy helps to reduce the volume of these hormones. However, if after undergoing hormonal therapy, you start experiencing growth of the hormone dependent cancer, then you may need to treat this condition with some measures so as to improve survival.
Here are things you need to know about castration-resistant cancer.
Medications – Some of the best known treatments used to treat castration-resistant prostate cancer (CRPC) include Docetaxel and Cabazitaxel. These drugs have the approvals of the FDA, and have been known to improve the survival rate of the prostate cancer victim. These are often applied as part of the chemotherapy treatment.
Another effective drug for the management of castration-resistant prostate cancer (CRPC) is the oral drug, Ketoconazole and a combination of other drugs like Thalidomide, Bevacizumab, and Prednisone. These have the capacity to manipulate the hormone causing castration-resistant prostate cancer (CRPC). It has been shown that they have minimal side effects. Management of CRPC with these medications has shown to improve the survival rate of patients by more than 4 months.
Apart from some of the chemotherapy treatments mentioned above, immunotherapy treatments have equally shown to be effective in treating castration-resistant prostate cancer (CRPC) and other forms of metastatic prostate cancer. Sipuleucel-T and Abiraterone Acetate are FDA approved immunotherapy that can be applied to treat late stage or metastatic prostate cancer. These can be applied before chemotherapy treatment.
So, the above paragraphs highlight some of the best known treatments for castration-resistant prostate cancer (CRPC). This form of prostate cancer can be deadly and offers the victim little chance of survival. Thankfully, with thorough research efforts the use of drugs and other treatment options has been developed to help manage the symptoms of this condition. People that have been diagnosed with late stage prostate cancer have more to benefit with the treatments.
Conclusively, if you have been diagnosed with prostate cancer and you have been diagnosed with CRPC, then your doctor can provide you details on how your treatment is going to look like. Consult with him to know the treatment options you have and the possible side effects. It is important to still have realistic expectations when it comes to the medications or management of castration-resistant prostate cancer (CRPC).
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)